openPR Logo
Press release

Insulin Delivery Devices Market is Projected to Reach Market Valuation of US$ 21,783.3 Mn through 2026

08-13-2020 04:19 AM CET | Health & Medicine

Press release from: Transparency Market Research

Insulin Delivery Devices Market is Projected to Reach Market

Transparency Market Research (TMR) has published a new report titled ‘Insulin Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 to 2026.’ According to the report, the global insulin delivery devices market was valued at US$ 10,385.0 Mn in 2017 and is projected to reach US$ 21,783.3 Mn by 2026, expanding at a high CAGR of 8.7% from 2018 to 2026. Increase in the prevalence rate of diabetes and related diseases across the world is anticipated to fuel the global insulin delivery devices market during the forecast period.

Read Report Overview - https://www.transparencymarketresearch.com/insulin-delivery-devices-market-2018-2026.html

North America and Europe are expected to dominate the global market during the forecast period. The market in these regions is primarily driven by an increase in government initiatives and a highly structured health care industry. The market in Europe is projected to expand at a CAGR of 7.7% from 2018 to 2026. The market in Asia Pacific is anticipated to expand at a high CAGR of 10.4% from 2018 to 2026. The insulin delivery devices market in Latin America is likely to expand at a moderate growth rate during the forecast period.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=52368

Increase in Preference for Insulin Pens to Boost Market

In terms of product, the insulin pens segment is projected to account for a dominant share of the global insulin delivery devices market during the forecast period. The segment is anticipated to expand at a CAGR of 8.4% from 2018 to 2026. High adoption rate, rising popularity among consumers, and user-friendly design of insulin pens are contributing to the significant revenue share of this segment. An increase in focus of manufacturers on promoting innovation and advanced technology is another key factor contributing to the high share. The insulin pumps segment held a major share of the market, due to an increase in preference for non-invasive insulin delivery systems. The insulin syringe and other segments accounted for around 27.0% share of the global insulin delivery devices market, in terms of revenue, in 2017.

Hospital Pharmacy Segment to Expand at a Significant CAGR

Based on distribution channel, the hospital pharmacy segment accounted for a leading share of the global insulin delivery devices market in 2017. It is projected to lose market share by the end of 2026. The segment is anticipated to expand at a CAGR of 8% during the forecast period due to a rise in the demand for insulin delivery devices from a large diabetic patient population undergoing surgical procedures in hospitals. Online sales was a prominent segment of the market in 2017. This is due to an increase in the number of Internet users and rise in inclination toward e-commerce for the purchase of insulin delivery devices. This, in turn, is likely to drive the clinical laboratories segment during the forecast period.

Request for Analysis of COVID19 Impact on Insulin Delivery Devices Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=52368

North America to be a Highly Lucrative Region of the Insulin Delivery Devices Market

The insulin delivery devices market in North America is driven by high prevalence of diabetes in the U.S. and an increase in demand for reusable pens with advanced technology. North America has an edge in the global insulin delivery devices market. Moreover, major factors such as aging population, highly structured health care industry, and availability of well-defined reimbursement policies from public and private health insurance firms fuel the insulin delivery devices market in the U.S. North America is expected to dominate the market during the forecast period due to early availability of advanced technologies and higher penetration of diabetes care services across the region. Moreover, a large number of players in the U.S. are focusing on R&D in order to introduce new products. The U.S. is an early adopter of innovative products, as most pharmaceutical products are first launched in the country. This is likely to boost the market in the country in the near future.

Purchase Insulin Delivery Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=52368<ype=S

Trend of Strategic Alliances with Local Companies to Strengthen Distribution Networks and Expand Geographic Presence

The global insulin delivery devices market is fragmented, owing to the presence of several small- and large-scale companies. However, the market is dominated by a few major players with a strong global presence. The report provides profiles of leading players operating in the global insulin delivery devices market. Key players in the market include B. Braun Melsungen AG, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Medtronic plc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Biocon Ltd., Owen Mumford Ltd., Ypsomed Holding AG, Cellnovo Group SA., Valeritas, Inc., Insulet Corporation, SOOIL Developments Co., Ltd, MannKind Corporation, and Tandem Diabetes Care, Inc.

More Trending Reports by Transparency Market Research –

Diagnostic Imaging Services Market: http://www.prnewswire.com/news-releases/increasing-adoption-of-new-technology-to-help-diagnostic-imaging-services-market-reach-valuation-worth-us465-bn-by-2027-transparency-market-research-301008184.html

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Delivery Devices Market is Projected to Reach Market Valuation of US$ 21,783.3 Mn through 2026 here

News-ID: 2111130 • Views: 256

More Releases from Transparency Market Research

Endoscopy Repair MarketSet for Rapid Growth and Trend, by 2025
Global Endoscope Repair Market: Overview An endoscope is an instrument used to view any internal cavity of the human body. Endoscopes are inserted into the body via one of many natural orifices. A high resolution camera at the end of inert tubing allows visualization of the body from inside and makes clinical decision making easier. Endoscopes are made of inert material like polyurethane which resists corrosion from bodily fluids and is
Nasal Oxygen Cannula Marketto Set Phenomenal Growth by 2026
Global Nasal Oxygen Cannula Market: Overview A cannula is any tube inserted into the body. A nasal cannula is an oxygen conduit used to deliver high concentrations of oxygen to patients through the nose. Traditionally made of rubber, current versions are made of plastic and can be connected to any oxygen supply by a pliable universal connector. This allows easy adaptability of this product to any setting, for in patient or
Medically Supervised Weight Loss Service MarketShares, Strategies, and Forecasts …
Global Medically Supervised Weight Loss Service Market: Overview Obesity has reached concerning levels around the world, with an increasing number of people tipping the scales. 69% of Americans are estimated to be overweight or obese at this point in time. Excess weight is increasingly linked with a number of chronic diseases that figure as the top causes of mortality worldwide. Also, popular human aesthetics are pushing people towards a fitter body
Bone Conduction Hearing Devices Market: Business Overview and Global Development …
Global Bone Conduction Hearing Devices Market: Snapshot Growing instances of hearing issues among older population is working as a driving factor for the growth of the global bone conduction hearing devices market. Bone conduction hearing devices are gaining popularity in all worldwide populace owing to their ability to work as a substitute to conventional hearing devices. These devices are used by people who are suffering from hearing issues related to miss

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin
Insulin Delivery Devices Market - Insights
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin
Biosimilar Insulin Market Access
Boston, MA ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact